Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Chlortetracycline hydrochloride
aniMedica GmbH
QD06AA02
Chlortetracycline hydrochloride
3.21 gram/spray container
Cutaneous spray, suspension
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Pigs, Sheep
chlortetracycline
Antibacterial
Authorised
2008-10-24
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Animedazon Spray, 2.45 % w/w cutaneous spray, suspension for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each spray container contains: ACTIVE SUBSTANCE: Chlortetracycline hydrochloride 3.210 g (equivalent to 2.45 % w/w) (equivalent to chlortetracycline 2.983 g) EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS QUANTITATIVE COMPOSITION IF THAT INFORMATION IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE VETERINARY MEDICINAL PRODUCT_ _ Patent Blue V 85 % (E 131) 0.23 g Isobutane (Propellant) 92.2 g Isopropyl alcohol Sorbitan trioleate Silica colloidal anhydrous Evenly blue coloured spray 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle, sheep, pigs 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES Treatment of superficial traumatic or surgical wounds contaminated with chlortetracycline-sensitive agents. The veterinary medicinal product can be used as part of a treatment for superficial skin and claw infections, in particular interdigital dermatitis (foot rot, foul in the foot) and dermatitis digitalis (Mortellaro disease), caused by micro-organisms sensitive to chlortetracycline. 3.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in cases of known resistance to tetracyclines. 3.4 SPECIAL WARNINGS None. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: Protect the eyes of the animal when spraying in the vicinity of the head. Clean the affected area thoroughly before spraying. Use of the veterinary medicinal product should be based on identification and susceptibility testing of the target pathogen(s). If this is not possible, therapy should be based on epidemiological information and knowledge of susceptibility of the target pathogen(s) at farm level, or at local/regional level. Use of the veterinary medicinal product should be in accordance with official, national and regional antimicrobial policies. The animal should Read the complete document